Yes—you should always mention memory supplements before cognitive testing. Memory supplements like Ginkgo biloba and piracetam demonstrably alter how you perform on cognitive tests, and standard neuropsychological assessment protocols require you to disclose all medications and supplements as part of the intake process. Your neuropsychologist needs this information to interpret your test results accurately. Without knowing whether you take supplements, clinicians cannot tell whether your score reflects your actual untreated cognitive capacity or an artificially elevated baseline—a distinction that becomes critical if you take a follow-up test later to track any real cognitive change.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Why Supplements Must Be Disclosed
- How Memory Supplements Affect Test Results
- Why Baseline Testing Matters Most
- What to Disclose and When
- The Risk of Undisclosed Supplements
- Frequently Asked Questions
Why Supplements Must Be Disclosed
Neuropsychological assessments work by establishing a baseline—a snapshot of your current cognitive abilities—that later tests can be compared against. If that baseline is inflated by supplements, any actual decline in cognition will appear smaller or hidden at the next testing, potentially delaying diagnosis or masking important changes in brain health.
Penn Medicine's neuropsychological testing guidance and clinical trial protocols both emphasize that supplement and medication disclosure is non-negotiable. The reason: cognitive-enhancing supplements are active agents that change test performance, just as much as prescription medications do.
How Memory Supplements Affect Test Results
Research has documented that piracetam produces significant improvements in cognitive and working memory across performance levels on standard psychometric tests. Ginkgo biloba similarly modifies cognitive function. These are not small effects—they meaningfully shift your test score upward during the assessment itself.
Clinical researchers take this so seriously that trials testing cognitive-enhancing drugs require participants taking memory supplements to complete a 7- to 30-day washout period before baseline testing. This washout exists for one reason: to ensure test scores reflect untreated capacity, not supplement-boosted performance. Between 2.7% and 27.9% of baseline cognitive test results show validity concerns due to medication and supplement use, meaning the problem is both common and quantifiable.
Why Baseline Testing Matters Most
The first cognitive test you take is the most critical disclosure point. That baseline becomes the reference for every future test—whether six months, two years, or five years from now. If you undisclosed supplements inflate your baseline, clinicians will mistakenly think your brain is healthier than it actually is. Imagine taking a memory supplement before your first test (baseline: 120).
Later, you stop the supplement and your genuine cognitive capacity declines slightly (real capacity: 115). On your second test without the supplement, you score 115. Your clinician might see 120 → 115 and miss the underlying decline, or misinterpret it. With full disclosure at baseline, the clinician would know the true comparison and catch real changes.
What to Disclose and When
Bring a complete list of all memory supplements to your neuropsychological evaluation—not just prescription medications. This includes Ginkgo biloba, piracetam, omega-3s marketed for brain health, high-dose B vitamins, medium-chain triglycerides, and any others. Include dosages and how long you have been taking them.
Disclose this information before your first test, before any follow-up tests, and especially if you plan to start or stop a supplement between assessments. Tell the neuropsychologist during intake, not casually after testing starts. This transparency takes a few minutes but protects the accuracy of your entire testing record.
The Risk of Undisclosed Supplements
If you don't mention supplements and they affect your score, your clinician cannot accurately interpret what the results mean. They might suspect cognitive decline that is not real, or miss subtle changes that are real. More practically, supplement and medication status is a documented confounding variable in cognitive research—your baseline supplement use modifies how you will respond to later interventions or treatments, and undisclosed use can mask or exaggerate treatment effects at follow-up testing.
Neuropsychologists are trained to factor in supplement use when they know about it. They are not trained to guess. Omitting this information transfers risk directly to the quality of your care.
Frequently Asked Questions
Do I need to stop taking supplements before cognitive testing?
Not necessarily. The standard protocol is to continue your usual routine and simply report what you take. However, some clinicians may ask you to stop certain supplements before testing, or they may adjust how they interpret your results based on supplement use. Ask your neuropsychologist directly about their protocol during scheduling.
What if I forgot to mention a supplement at my first test?
Tell your neuropsychologist before your next appointment. They can note this in your chart and adjust their interpretation of both your baseline and any follow-up results. The sooner you disclose, the more accurate your full testing record becomes.
Does caffeine count as a supplement I need to disclose?
Yes. Caffeine affects alertness and performance on cognitive tests. Mention your usual intake (coffee, tea, energy drinks, pills) so the clinician knows whether you arrived at testing in your typical state or unusually caffeinated or withdrawn.
